Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SUMO2 pseudogene 4 (SUMO2P4) is a pseudogene related to the functional SUMO2 gene, which encodes a member of the small ubiquitin-like modifier (SUMO) protein family. Pseudogenes are non-functional, defunct genomic DNA sequences similar to normal genes but typically lack the ability to encode a functional protein. There is no evidence that SUMO2P4 is transcribed or produces any protein product; it does not act as a receptor, enzyme, transporter, or other therapeutic target family member. Several pseudogenes have been reported for the SUMO gene family, and like most pseudogenes, SUMO2P4 is not considered a therapeutic target and has no known biological function or role in disease[3][5]. Any reference to SUMO2P4 in drug discovery or mechanism of action would be incorrect, as it is not a functional gene product.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SUMO2 pseudogene 4 (SUMO2P4).